|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.20 USD | +0.14% |
|
+1.65% | -81.74% |
| 10/12 | Sarepta Therapeutics' Myotonic Dystrophy Type 1 Trial Data Could Boost Investor Sentiment, Oppenheimer Says | MT |
| 09/12 | Sarepta Offers 'Attractive' Entry Point After Setbacks, Wedbush Says | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Official Publications
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















